SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356090-24-000010
Filing Date
2024-05-14
Accepted
2024-05-14 17:23:45
Documents
86
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pgen-20240331.htm   iXBRL 10-Q 945698
2 EX-31.1 pgen-20240331xexx311.htm EX-31.1 10375
3 EX-31.2 pgen-20240331xexx312.htm EX-31.2 10038
4 EX-32.1 pgen-20240331xexx321.htm EX-32.1 5801
5 EX-32.2 pgen-20240331xexx322.htm EX-32.2 5878
  Complete submission text file 0001356090-24-000010.txt   5764697

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pgen-20240331.xsd EX-101.SCH 46001
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pgen-20240331_cal.xml EX-101.CAL 73384
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pgen-20240331_def.xml EX-101.DEF 189345
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pgen-20240331_lab.xml EX-101.LAB 527854
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pgen-20240331_pre.xml EX-101.PRE 373821
90 EXTRACTED XBRL INSTANCE DOCUMENT pgen-20240331_htm.xml XML 703114
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36042 | Film No.: 24945851
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)